Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

Sting1 Knockout RAW 264.7 Cell Line

The Sting1 Knockout RAW 264.7 Cell Line is a CRISPR/Cas9-edited murine macrophage cell line with targeted disruption of the Sting1 gene, encoding the STING adaptor…
Cat. No. ARG44139

Sting1 Knockout RCS Cell Line

Sting1 Knockout RCS Cell Line is a CRISPR/Cas9-edited knockout cell line derived from rat chondrosarcoma-derived chondrocyte-like RCS cells. This model eliminates STING1 (TMEM173), a critical…
Cat. No. ARG44138

STING1 Knockout SW1353 Cell Line

The STING1 Knockout SW1353 Cell Line is a CRISPR/Cas9-edited knockout model in the human SW1353 chondrosarcoma cell background, which endogenously expresses cartilaginous matrix and exhibits…
Cat. No. ARG44137

Sting1 Knockout B16-F10 Cell Line

The Sting1 Knockout B16-F10 Cell Line is a CRISPR/Cas9-edited murine melanoma cell line with targeted disruption of the Sting1 gene, encoding the stimulator of interferon…
Cat. No. ARG44136

STC2 Knockout HEK293T Cell Line

The STC2 Knockout HEK293T Cell Line is a CRISPR/Cas9-edited human embryonic kidney cell line with targeted disruption of the STC2 gene, encoding the secreted glycoprotein…
Cat. No. ARG44135

STAT3 Knockout HEK293 Cell Line

The STAT3 Knockout HEK293 Cell Line is a CRISPR/Cas9-edited knockout cell line with targeted disruption of the STAT3 gene, eliminating the STAT3 transcription factor. STAT3…
Cat. No. ARG44134

STAT2 Knockout A549 Cell Line

The STAT2 Knockout A549 Cell Line is a CRISPR/Cas9-edited knockout cell line providing a genetically defined loss-of-function model for STAT2, a critical transcription factor in…
Cat. No. ARG44133

STAT1 Knockout A549 Cell Line

The STAT1 Knockout A549 Cell Line is a CRISPR/Cas9-edited lung adenocarcinoma epithelial cell line with targeted disruption of STAT1, a central transcription factor in interferon…
Cat. No. ARG44132

SQSTM1 Knockout SK-OV-3 Cell Line

The SQSTM1 Knockout SK-OV-3 Cell Line is a CRISPR/Cas9-edited human ovarian adenocarcinoma cell model with targeted disruption of the SQSTM1 gene. This product enables loss-of-function…
Cat. No. ARG44131

Sqstm1 Knockout RAW 264.7 Cell Line

The Sqstm1 Knockout RAW 264.7 Cell Line is a CRISPR/Cas9-edited murine macrophage model with targeted disruption of the Sqstm1 gene, encoding the autophagy receptor and…
Cat. No. ARG44130

SPINK2 Knockout THP-1 Cell Line

The SPINK2 Knockout THP-1 Cell Line is a CRISPR/Cas9-edited knockout of the serine protease inhibitor SPINK2 in the human monocytic leukemia THP-1 cell line (PTEN-null,…
Cat. No. ARG44129

SOX9 Knockout HEK293 Cell Line

The SOX9 Knockout HEK293 Cell Line is a CRISPR/Cas9-edited knockout model derived from human embryonic kidney HEK293 cells, designed for loss-of-function studies of the SOX9…
Cat. No. ARG44128

Loading products...